Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on July 1, 2025
Children’s Health Fund Appoints Anne Grissinger to Board of Directors
EIN Presswire
·
July 1, 2025
Seasoned Strategy Consultant and Nonprofit Leader to Help Advance Mission of Expanding Access to Children’s Health Care NEW YORK, NY, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Children’s Health Fund (CHF) today announced the appointment of Anne …
Pet Acoustics Launches Groundbreaking Pet Acoustics+ App: First Mobile Hearing Test & Calming Music Platform for Pets
EIN Presswire
·
July 1, 2025
Pet Acoustics+ app launches with the first mobile hearing test for pets and calming music to ease anxiety, fears, …
New AI Tool Finds Seniors Overpaying an Average of $4,300 a Year on Medicare—Uncovers $137 Billion in Potential Savings.
EIN Presswire
·
July 1, 2025
Study shows 77% of seniors could save over $1,000 a year by switching plans with new tool; 95% of PDP users would benefit from Medicare Advantage. NEW YORK, NY, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- One …
HealthBenefits.co.in Launches Global Wellness Platform with Smart Health Tracking Tools
EIN Presswire
·
July 1, 2025
HealthBenefits.co.in empowers everyday users with free tracking tools, health calculators, and beginner-friendly wellness content. NEW YORK, NY, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Health-conscious Americans and global users now have a …
Design Studio UI/UX Establishes Footprints Across 5 US Powerhouses: Hyper-Local UI/UX & Web Design Services Go Live
EIN Presswire
·
July 1, 2025
LA. NYC. SF. Seattle. Austin. Local firms in these cities can now team up with the award-winning UI/UX design agency for conversion-focused design services. NEW YORK, NY, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- Design Studio UI/UX - an award …
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and Human …
Goji Crazy for the Red, White & Blue Bowl at Frutta Bowls
GlobeNewswire
·
July 1, 2025
St. Petersburg, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Frutta Bowls, known for its specialty acai bowls and smoothies made with better-for-you ingredients, is turning up the flavor — and the fun — just in time for the Fourth of July. Starting today, all …
Pennant Announces Home Health Acquisition in Southern California
GlobeNewswire
·
July 1, 2025
EAGLE, Idaho, July 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of a premier home health …
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
GlobeNewswire
·
July 1, 2025
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry Collaboration Builds a Seamless NovoCare® Pharmacy …
Vireo Growth Inc. and Curio Wellness Announce Manufacturing and Distribution Partnership
GlobeNewswire
·
July 1, 2025
-- Leading cannabis companies partner to leverage existing IP and brand value in New York -- CHICAGO and MINNEAPOLIS, July 01, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), a multi-state, vertically- …
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
GlobeNewswire
·
July 1, 2025
HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, 2025, as the date of its 2025 annual …
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 1, 2025
PASADENA, CALIF, July 01, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered into a definitive agreement with …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
July 1, 2025
NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it …
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
GlobeNewswire
·
July 1, 2025
ORR of 50% in treatment-naïve patients with HPV+ R/M HNSCC 12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CHARLESTOWN, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 105,330 restricted …
Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction
GlobeNewswire
·
July 1, 2025
TORONTO, July 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on June 30, 2025, the Company exchanged $6.5 million of its subordinated …